Mateos, M., Hari, P., Bahlis, N., Chari, A., Donk, N. v. d., Dholaria, B., . . . Askari, E. (2022). B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS. Wiley.
Chicago Style (17th ed.) CitationMateos, M., et al. B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS. Wiley, 2022.
MLA (9th ed.) CitationMateos, M., et al. B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS. Wiley, 2022.
Warning: These citations may not always be 100% accurate.